# Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer

> **NCT02275871** · NA · TERMINATED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 44 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** MRI
- **OTHER:** CESM

## Key facts

- **NCT ID:** NCT02275871
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** Didn't have funding to support the study design
- **Last updated:** 2020-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02275871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02275871, "Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02275871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*